Genasense Injection To Go Before ODAC
This article was originally published in The Pink Sheet Daily
Executive Summary
Genta's chronic lymphocytic leukemia treatment Genasense will be reviewed by FDA's Oncology Drugs Advisory Committee Sept. 6, the firm said July 27